Danish pharmaceutical company Novo Nordisk briefly topped the list of Europe’s most valuable companies after the French company LVMH, which owns the Louis Vuitton and Dior brands. This has been reported Bloomberg.
According to the agency, at the opening of trading in Copenhagen on September 1, Novo Nordisk shares reached DKK 1,287.4 per share. Thus, while the market value of the entire company reached 421 billion dollars, it was noted that LVMH’s shares in Paris fell to 772.6 euros per share, and the capital of the group reached 420.6 billion dollars.
Subsequently, the Danish company’s share price fell to 1,283.2 kroner (capital value of 419.6 billion dollars), while LVMH securities rose to 784.9 euros, bringing its market value to 426.2 billion dollars.
According to Bloomberg, this was due to the success of the company’s injectable weight loss drugs Wegovy and Ozempic.
Novo Nordisk shares have more than quadrupled since the end of 2018, according to the agency.
Kokoc Group in July published According to the study, almost 40% of respondents did not feel any decrease in drug availability in Russia. At the same time, 9% of respondents were able to replace inaccessible drugs with Russian-made drugs. 20% found analogues for buyers in Russia. And 30% of the respondents were in no way able to replace the missing medicines in the Russian Federation.
sharply in Russia augmented beer imports.